CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity
Authors
Shuki Oya,
Hidetoshi OzawaTakayuki Nakamura,
Akira Mori,
S. Ochi,
Yoshimi Maehiro,
Masahiro Umeda,
Yusuke Takaki,
Toshinobu Fukuyama,
Yoshitaka Yamasaki,
Maki Yamaguchi,
Kazutoshi Aoyama,
Fumihiko Mouri +11 authors
,
Koji Nagafuji Tip Tip